Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velmanase Alfa in Alpha-Mannosidosis (SHAMAN)
NCT04031066Phase 3Withdrawn
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2021
- Primary completion
- Oct 2021
- Modality
- Replacement Enzymes
01
Overview
A Phase 3 trial of velmanase alfa in alpha-mannosidosis, sponsored by Chiesi Farmaceutici S.p.A.. Planned start Jan 2021; status: withdrawn.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on NCT04031066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04031066.